ME NewsWire / BusinessWire

RESEARCH TRIANGLE PARK, N.C - Tuesday, September 17th 2013

Quintiles today announced that it has completed the previously announced acquisition of Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors.

"We are extremely pleased to have completed the acquisition of Novella and look forward to working together to increase our collective opportunities with emerging oncology and medical device companies,” said Paula Brown Stafford, president, Clinical Development at Quintiles. "With the transaction now officially closed, we will focus our efforts on leveraging Quintiles’ global resources and capabilities with the expertise and personal attention of Novella to continue to deliver the high-quality services customers have come to expect from both companies.”

Now known as "Novella Clinical, a Quintiles c ... Read more »

LONDON - Tuesday, September 17th 2013 [ME NewsWire]

(BUSINESS WIRE) EY is the world’s most attractive professional services employer – and second most attractive employer overall – in Universum’s annual World’s Most Attractive Employer ranking.

Based on the preferences of almost 94,000 business students from the world’s top academic institutions in the largest 12 economies by GDP, EY is now the second most attractive employer globally and the highest ranking choice among leading professional services organizations.

As well as ranking as the leading professional services organization in six out of the twelve markets, EY also featured as one of the top fifteen employers overall in Australia, Canada, France, Germany, India, Italy, Russia, United Kingdom and the United States.

"We congratulate EY for its great achievement. Being seen by students as an ideal employer is something to be celebrated. As a CEO, I understand the value in being able to attract, recruit ... Read more »

Boehringer Ingelheim plans to work closely with the US Food and Drug Administration (FDA) to potentially provide a new treatment option to improve survival related outcomes for patients with acute myeloid leukaemia (AML)

INGELHEIM, Germany - Tuesday, September 17th 2013 [ME NewsWire]

(BUSINESS WIRE)--For non-U.S. media only

Boehringer Ingelheim is pleased to announce that the FDA has granted a Breakthrough Therapy Designation to volasertib*, a selective and potent polo-like kinase (Plk) inhibitor, for the treatment of patients with AML, a type of blood cancer.

"Volasertib’s* innovative mode of action offers a new approach and may potentially provide a new therapy option for AML patients who have a high unmet medical need,” said Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim. "We are looking forward to exploring opportunities with the FDA to expedite the final stage of the development of volasertib* with the aim of makin ... Read more »

AMSTERDAM - Tuesday, September 17th 2013 [ME NewsWire]

(BUSINESS WIRE) Regulatory News:

Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, is working with LifeMed ID to provide a robust eHealthcare solution that securely authenticates patient’s identities at Maine’s Mid Coast Hospital. The solution digitally stores and verifies identification credentials enabling secure access to the patients’ unique Electronic Medical Records (EMR). Gemalto’s advanced Sealys MultiApp ID smart cards in collaboration with LifeMed ID’s SecureReg solution enables Maine’s Mid Coast Hospital to safeguard patient medical information by authenticating the identity of the patient to reduce administrative time, cost and paperwork, improving the overall quality of care.

The new system gives Mid Coast Hospital an end-to-end secure authentication infrastructure across disparate groups within the healthcare landscape for advancements in eHealth. Assigning various degrees ... Read more »

ALEXANDRIA, Va - Tuesday, September 17th 2013 [ME NewsWire]

(BUSINESS WIRE) Mandiant®, the leader in security incident response management, today announced the expansion of its European operations including a new office in the London area, key hires to direct sales in the region and new agreements with channel partners. The announcement was made in London at the opening of the Gartner Security & Risk Management Summit, where Mandiant is exhibiting on 18th-19th October.

"Organizations in Europe and around the world are routinely compromised by attackers that seek to steal their financial assets and intellectual property,” said Mandiant Chief Executive Officer Kevin Mandia. "Mandiant is committed to helping organizations across Europe attack their security gap by equipping them with the tools, intelligence and expertise required to find and stop attackers that bypass their preventive computer security measures.”

To support its expansion in Europe, Mandiant ha ... Read more »

ME Newswire / Business Wire

NEW YORK - Tuesday, September 17th 2013

Zafin is excited to announce that Michael Sgroe has joined the company as President.

Mike arrives at a most appropriate time in Zafin’s journey. With his strong banking and product business background, Mike will be instrumental in helping the company excel through its planned strategic growth. Based in New York City, a major financial center, Mike gives Zafin its first New York address.

Prior to joining Zafin, Mike helped increase Fundtech’s value tenfold while supporting the expansion of the company’s strong global footprint. His impressive career boasts over 30 years of experience in the financial services industry, most recently as President and COO of Fundtech. Mike’s understanding of the financial services market and deep product knowledge will bolster Zafin’s quest to bring Product and Pricing Lifecycle Management to banks across the globe.

"I am thrilled to have Mike join our l ... Read more »